pharmaceutical corporations

Responding to the announcement that COVAX has received more funding and is planning to accelerate its vaccine rollout, Oxfam International’s Head of Inequality Policy, Max Lawson, said: “More funding for COVAX and a quicker rollout of vaccines is a small piece of good news for developing countries struggling to get the doses they need, but at best fewer than a quarter of people in these countries will have been vaccinated by the end of the year."

Max Lawson, Head of Inequality Policy at Oxfam, said: "This G7 summit will live on in infamy. Faced with the biggest health emergency in a century and a climate catastrophe that is destroying our planet, they have completely failed to meet the challenges of our times. Never in the history of the G7 has there been a bigger gap between their actions and the needs of the world."

Responding to news that G7 leaders are collectively planning to pledge at least 1 billion COVID-19 vaccine doses to poorer countries, Oxfam's Health Policy Manager Anna Marriott said: "If the best G7 leaders can manage is to donate 1 billion vaccine doses then this summit will have been a failure. It is estimated that the world will need 11 billion doses to end the pandemic."

Responding to early reports of G7 leaders agreeing a 'Carbis Bay Declaration' to end future pandemics faster, Oxfam's Health Policy Manager Anna Marriott said: "It's welcome that G7 leaders are planning measures to end future pandemics faster, but the lack of urgent action to end the current crisis is unforgiveable."

Anna Marriott, Oxfam Health Policy Manager and Policy co-lead for the People’s Vaccine Alliance said: "The 2021 Global Health Summit ended today in danger of being judged an historical failure of global solidarity to tackle a Covid-19 pandemic that is still, around the world, in its first expanding phase and yet to peak."

At least nine people have become new billionaires since the beginning of the COVID pandemic, thanks to the excessive profits pharmaceutical corporations with monopolies on COVID vaccines are making, The People’s Vaccine Alliance revealed today ahead of a G20 leaders Global Health Summit.

The United States government last night moved to support a waiver of intellectual property protections of the Covid-19 vaccine. The People’s Vaccine Alliance has been campaigning to suspend Covid-19 intellectual property protections and has this reaction: This is the decision the world needed: by backing a waiver of intellectual property protections for Covid-19 vaccines the Biden Administration can increase the global supply of vaccines and deal a deathblow to the Covid-19 pandemic.

Ahead of shareholder meetings for the giant pharmaceutical corporations, the People’s Vaccine Alliance calculates that Pfizer, Johnson & Johnson and AstraZeneca have paid out $26 billion in dividends and stock buybacks to their shareholders in the past 12 months.

Responding to the G20 Finance Ministers’ meeting today, Nadia Daar, Head of Oxfam’s Washington DC Office, said: "The G20 is not delivering on its promise to rebalance the global economy and provide major relief. It has simply extended a freeze on bilateral debt-service payments through year-end, pushing the can down the road once again. If debt cancellation is not part of the solution, the world’s poorest countries will continue to struggle to cope with the pandemic and its devastating effects. 
 

In response to calls for a waiver of Trade and Intellectual Property Rules (TRIPS) for COVID-19 vaccines, which is backed by more than 100 mostly developing countries, being blocked again at World Trade Organisation talks by rich countries, Oxfam’s Health Policy Manager, Anna Marriott, said:“This is a massive missed opportunity to speed up and scale up the production of lifesaving vaccines worldwide by waiving the intellectual property barriers that prevent more qualified manufacturers joining the effort.